| Primary |
| Deep Vein Thrombosis |
37.5% |
| Thrombosis Prophylaxis |
25.0% |
| Coronary Artery Disease |
12.5% |
| Prophylaxis |
12.5% |
| Pulmonary Embolism |
12.5% |
|
| Abdominal Wall Haematoma |
14.3% |
| Gastric Haemorrhage |
14.3% |
| Heparin-induced Thrombocytopenia |
14.3% |
| Heparin-induced Thrombocytopenia Test Positive |
14.3% |
| Hip Fracture |
14.3% |
| Metabolic Acidosis |
14.3% |
| Retroperitoneal Haemorrhage |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
42.4% |
| Embolism Arterial |
9.6% |
| Drug Use For Unknown Indication |
6.4% |
| Thrombosis Prophylaxis |
6.4% |
| Suicide Attempt |
4.8% |
| Antiplatelet Therapy |
4.0% |
| Cellulitis |
3.2% |
| Endocarditis |
3.2% |
| Pulmonary Oedema |
3.2% |
| Hypertension |
2.4% |
| Rectal Cancer |
2.4% |
| Coronary Arterial Stent Insertion |
1.6% |
| Glioblastoma Multiforme |
1.6% |
| Ischaemic Stroke |
1.6% |
| Lung Neoplasm Malignant |
1.6% |
| Peripheral Vascular Disorder |
1.6% |
| Pulmonary Embolism |
1.6% |
| Arthralgia |
0.8% |
| C-reactive Protein Increased |
0.8% |
| Dyspepsia |
0.8% |
|
| Somnolence |
15.4% |
| Activated Partial Thromboplastin Time Prolonged |
11.5% |
| Vomiting |
11.5% |
| Constipation |
3.8% |
| Death |
3.8% |
| Gastric Haemorrhage |
3.8% |
| Hepatitis Cholestatic |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Leukocytoclastic Vasculitis |
3.8% |
| Lung Neoplasm Malignant |
3.8% |
| Retroperitoneal Haematoma |
3.8% |
| Tachycardia |
3.8% |
| Tachypnoea |
3.8% |
| Thrombocytopenia |
3.8% |
| Thrombocytosis |
3.8% |
| Thrombosis In Device |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Vena Cava Thrombosis |
3.8% |
| Ventricular Drainage |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.7% |
| Drug Use For Unknown Indication |
13.8% |
| Prophylaxis |
7.5% |
| Pain |
3.4% |
| Plasma Cell Myeloma |
3.2% |
| Thrombosis Prophylaxis |
2.9% |
| Adverse Event |
2.7% |
| Constipation |
2.7% |
| Hypertension |
2.0% |
| Chronic Lymphocytic Leukaemia |
2.0% |
| Premedication |
1.4% |
| Pneumonia |
1.2% |
| Nausea |
1.1% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Hiv Infection |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Depression |
0.9% |
| Pulmonary Embolism |
0.9% |
| Antibiotic Therapy |
0.8% |
| Dyspepsia |
0.8% |
|
| Vomiting |
10.5% |
| Thrombocytopenia |
7.5% |
| Vertigo |
7.5% |
| Liver Function Test Abnormal |
6.8% |
| Pulmonary Embolism |
6.8% |
| Suicidal Ideation |
6.0% |
| Neutropenic Sepsis |
5.3% |
| Pneumonia |
5.3% |
| Hallucination, Visual |
4.5% |
| Hypomagnesaemia |
4.5% |
| Renal Failure Acute |
4.5% |
| Urticaria |
4.5% |
| Diarrhoea |
3.8% |
| Gastrointestinal Hypermotility |
3.8% |
| Pyrexia |
3.8% |
| Basal Cell Carcinoma |
3.0% |
| Hallucinations, Mixed |
3.0% |
| Hyperthermia |
3.0% |
| Hypoglycaemia |
3.0% |
| Sepsis |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
66.7% |
| Pulmonary Embolism |
22.2% |
| Deep Vein Thrombosis |
11.1% |
|
| Drug Interaction |
33.3% |
| Laboratory Test Abnormal |
33.3% |
| Spinal Subdural Haematoma |
33.3% |
|
